Antisecretory activity of pirenzepine versus cimetidine in man: a controlled study.
- 1 February 1984
- Vol. 25 (2) , 178-182
- https://doi.org/10.1136/gut.25.2.178
Abstract
Antisecretory effect of single oral therapeutic doses of pirenzepine (25 and 50 mg) and cimetidine (200 and 400 mg) was studied in 12 patients with duodenal ulcer. Gastric secretion was studied in basal condition and after stimulation with pentagastrin. Basal, maximum and peak acid output, basal and maximum acidity and basal and maximum volume were calculated after computerized correction for pyloric loss and duodenal reflux. Both drugs showed dose-related inhibition of all facets of gastric secretion. Cimetidine (200 mg) had a greater inhibitory effect on gastric basal secretion, but a similar effect on pentagastrin-stimulated secretion as with pirenzepine (50 mg). Cimetidine (400 mg) showed about twice the inhibitory activity of pirenzepine (50 mg) on basal stimulated secretion.This publication has 6 references indexed in Scilit:
- [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion].1980
- Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative studyPostgraduate Medical Journal, 1980
- DOUBLE-BLIND DOUBLE-DUMMY CROSSOVER COMPARISON OF THE EFFECT OF A SINGLE DOSE OF CIMETIDINE AND TRITHIOZINE ON GASTRIC-SECRETION1980
- [Action of some gastric antisecretory drugs on histamine H2-receptors (author's transl)].1978
- Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.British Journal of Clinical Pharmacology, 1975
- Statistical principles in experimental design.Published by American Psychological Association (APA) ,1962